Abstract:BackgroundGenome-scale CRISPR interference (CRISPRi) has been used in human cell lines; however, the features of effective guide RNAs (gRNAs) in different organisms have not been well characterized. Here, we define rules that determine gRNA effectiveness for transcriptional repression in Saccharomyces cerevisiae.ResultsWe create an inducible single plasmid CRISPRi system for gene repression in yeast, and use it to analyze fitness effects of gRNAs under 18 small molecule treatments. Our approach correctly identifies previously described chemical-genetic interactions, as well as a new mechanism of suppressing fluconazole toxicity by repression of the ERG25 gene. Assessment of multiple target loci across treatments using gRNA libraries allows us to determine generalizable features associated with gRNA efficacy. Guides that target regions with low nucleosome occupancy and high chromatin accessibility are clearly more effective. We also find that the best region to target gRNAs is between the transcription start site (TSS) and 200 bp upstream of the TSS. Finally, unlike nuclease-proficient Cas9 in human cells, the specificity of truncated gRNAs (18 nt of complementarity to the target) is not clearly superior to full-length gRNAs (20 nt of complementarity), as truncated gRNAs are generally less potent against both mismatched and perfectly matched targets.ConclusionsOur results establish a powerful functional and chemical genomics screening method and provide guidelines for designing effective gRNAs, which consider chromatin state and position relative to the target gene TSS. These findings will enable effective library design and genome-wide programmable gene repression in many genetic backgrounds.

CRISPR Interference (crispri) for Sequence-Specific Control of Gene Expression

Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

CRISPRi-mediated tunable control of gene expression level with engineered single-guide RNA in Escherichia coli

Precise Regulation of Cas9-Mediated Genome Engineering by Anti-CRISPR-Based Inducible CRISPR Controllers.

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression

Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system

Conditional Control of RNA-guided Nucleic Acid Cleavage and Gene Editing

Mobile-CRISPRi as a powerful tool for modulating gene expression

RNA-Responsive gRNAs for Controlling CRISPR Activity: Current Advances, Future Directions, and Potential Applications

CRISPRoff epigenetic editing for programmable gene silencing in human cells without DNA breaks

An enhanced CRISPR repressor for targeted mammalian gene regulation

Controlling CRISPR-Cas9 by guide RNA engineering

Multiplex gene regulation by CRISPR-ddCpf1

CRISPR/Cas13d-Mediated Microbial RNA Knockdown

Spatiotemporal control of CRISPR/Cas9 gene editing

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11